Volume 116, Issue 1, Pages (January 1999)

Slides:



Advertisements
Similar presentations
Volume 131, Issue 1, Pages (July 2006)
Advertisements

Proinflammatory cytokine–induced and chemical mediator–induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein.
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 114, Issue 5, Pages (May 1998)
Volume 68, Issue 4, Pages (October 2005)
Volume 115, Issue 6, Pages (December 1998)
The Fumagillin Analogue TNP-470 Inhibits DNA Synthesis of Vascular Smooth Muscle Cells Stimulated by Platelet-Derived Growth Factor and Insulin-like Growth.
MHC class II/CD38/CD9: a lipid-raft–dependent signaling complex in human monocytes by Marie-Thérèse Zilber, Niclas Setterblad, Thierry Vasselon, Christelle.
Volume 9, Issue 5, Pages (November 1998)
Volume 131, Issue 1, Pages (July 2006)
by Martha B. Johnson, and Caroline A. Enns
Volume 57, Issue 1, Pages (January 2000)
Volume 62, Issue 3, Pages (September 2002)
Involvement of Rab4 in regulated exocytosis of rat pancreatic acini
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
Volume 120, Issue 1, Pages (January 2001)
Volume 117, Issue 4, Pages (October 1999)
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Volume 114, Issue 4, Pages (April 1998)
Larry W. Kraiss, MDa,b,c, Neal M. Alto, BSa,c, Dan A
Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo  Markus Wagner, Martha E. Lopez, Mitch.
Volume 116, Issue 5, Pages (May 1999)
Volume 54, Issue 1, Pages (July 1998)
Angiotensin II-induced growth of vascular smooth muscle cells requires an Src- dependent activation of the epidermal growth factor receptor1  Dirk Bokemeyer,
Freimut Schliess, Anna Kordelia Kurz, Dieter Häussinger 
IGF-II-Mediated COX-2 Gene Expression in Human Keratinocytes Through Extracellular Signal-Regulated Kinase Pathway  Hye Jung Kim, Tae-Yoon Kim  Journal.
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Volume 117, Issue 3, Pages (September 1999)
Volume 118, Issue 6, Pages (June 2000)
Volume 121, Issue 6, Pages (December 2001)
Volume 65, Issue 6, Pages (June 2004)
Volume 57, Issue 6, Pages (June 2000)
Volume 119, Issue 2, Pages (August 2000)
Mechanisms of cross hyporesponsiveness to toll-like receptor bacterial ligands in intestinal epithelial cells  Jan-Michel Otte, Elke Cario, Daniel K.
Volume 68, Issue 4, Pages (October 2005)
Epidermal growth factor and transforming growth factor α down-regulate human gastric lipase gene expression  Eric Tremblay, Jean René Basque, Nathalie.
Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor  L.D. Alexander, Y. Ding, S. Alagarsamy,
Neurotensin receptor–1 and –3 complex modulates the cellular signaling of neurotensin in the HT29 cell line  Stéphane Martin, Valérie Navarro, Jean Pierre.
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Volume 60, Issue 6, Pages (December 2001)
Volume 122, Issue 2, Pages (February 2002)
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 128, Issue 4, Pages (April 2005)
Kellie J. White, Vincent J. Maffei, Marvin Newton-West, Robert A
Matrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytes  L.J. Raggatt, Ph.D., S.C. Jefcoat, M.S., I. Choudhury, Ph.D., S.
Volume 117, Issue 5, Pages (November 1999)
Volume 61, Issue 6, Pages (June 2002)
Volume 116, Issue 6, Pages (June 1999)
Volume 119, Issue 6, Pages (December 2000)
Volume 127, Issue 4, Pages (October 2004)
Lori Wilson, Csaba Szabó, Andrew L. Salzman  Gastroenterology 
Volume 118, Issue 1, Pages (January 2000)
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Volume 54, Issue 4, Pages (October 1998)
Volume 122, Issue 1, Pages (January 2002)
Silva H Hanissian, Raif S Geha  Immunity 
Volume 59, Issue 3, Pages (March 2001)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 55, Issue 2, Pages (February 1999)
Time-dependent effects of IL-6 on tyrosine phosphorylation of IRS-1.
Volume 114, Issue 5, Pages (May 1998)
Raghvendra Singh, Stelios T Andreadis  Molecular Therapy 
Larry D. Alexander, Suganthi Alagarsamy, Janice G. Douglas 
Volume 4, Issue 4, Pages (October 1999)
Volume 115, Issue 6, Pages (December 1998)
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Suppression of Keratinocyte Growth and Differentiation by Transforming Growth Factor β1 Involves Multiple Signaling Pathways  Alison L. Dahler, Lois L.
Volume 128, Issue 4, Pages (April 2005)
Presentation transcript:

Volume 116, Issue 1, Pages 78-89 (January 1999) Gastrin induces heparin-binding epidermal growth factor–like growth factor in rat gastric epithelial cells transfected with gastrin receptor  Yoshiji Miyazaki, Yasuhisa Shinomura, Shusaku Tsutsui, Shinichiro Zushi, Yoshifumi Higashimoto, Shuji Kanayama, Shigeki Higashiyama, Naoyuki Taniguchi, Yuji Matsuzawa  Gastroenterology  Volume 116, Issue 1, Pages 78-89 (January 1999) DOI: 10.1016/S0016-5085(99)70231-3 Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 (A) Expression of gastrin/CCK-B–receptor mRNA by transfected RGM1 cells. Total RNAs isolated from parental RGM1 (lane 1), RGaR9 (lane 2), and RGaR19 cells (lane 3) were loaded and hybridized with a cDNA probe for human gastrin/CCK-B receptor. A GAPDH probe was used to control for RNA loading. RGaR9 and RGaR19 cells express the 2.7-kb gastrin/CCK-B–receptor mRNA. (B) Scatchard plot analysis of 125I-labeled gastrin 17 saturation binding studies. RGaR9 cells were incubated with 0.1–2.0 nmol/L 125I-labeled gastrin 17 in the presence or absence of 10 μmol/L unlabeled gastrin 17. The specific binding activity was calculated by subtraction of the radioactivity of the sample containing 10 μmol/L unlabeled gastrin 17 from the total activity. Each point represents the mean of results from 3 separate experiments. The Kd value is 0.39 nmol/L, and the average number of binding sites per cell is 2.72 × 103. Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 (A) Induction of HB-EGF and AR mRNAs by gastrin 17. Quiescent RGaR9 cells were incubated in serum-free medium with 10−8 mol/L gastrin 17 for the indicated times. Total RNA isolated from the cells was loaded and hybridized with cDNA probes for rat HB-EGF and AR. Blots were rehybridized with a GAPDH cDNA probe. Autoradiographs are representative of 4 experiments. (B) Quantitation of HB-EGF (•) and AR (○) mRNAs in A. Error bars indicate mean ± SE (n = 4). (C) Inhibition of gastrin-induced expression of HB-EGF and AR mRNAs by the gastrin/CCK-B–receptor antagonists. Quiescent RGaR9 cells were incubated in serum-free medium with 10−8 mol/L gastrin 17/CCK-8 for 2 hours under the following conditions: lane 1, untreated; lane 2, gastrin 17; lane 3, CCK-8; lane 4, gastrin 17 with L-740,093 (10 nmol/L); lane 5, gastrin with L-365,260 (100 nmol/L). Autoradiographs are representative of 4 experiments. Normalized hybridization signals of HB-EGF mRNA are expressed in relationship to values in gastrin-treated cells (lower panel). Error bars indicate means ± SE (n = 4). Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 2 (A) Induction of HB-EGF and AR mRNAs by gastrin 17. Quiescent RGaR9 cells were incubated in serum-free medium with 10−8 mol/L gastrin 17 for the indicated times. Total RNA isolated from the cells was loaded and hybridized with cDNA probes for rat HB-EGF and AR. Blots were rehybridized with a GAPDH cDNA probe. Autoradiographs are representative of 4 experiments. (B) Quantitation of HB-EGF (•) and AR (○) mRNAs in A. Error bars indicate mean ± SE (n = 4). (C) Inhibition of gastrin-induced expression of HB-EGF and AR mRNAs by the gastrin/CCK-B–receptor antagonists. Quiescent RGaR9 cells were incubated in serum-free medium with 10−8 mol/L gastrin 17/CCK-8 for 2 hours under the following conditions: lane 1, untreated; lane 2, gastrin 17; lane 3, CCK-8; lane 4, gastrin 17 with L-740,093 (10 nmol/L); lane 5, gastrin with L-365,260 (100 nmol/L). Autoradiographs are representative of 4 experiments. Normalized hybridization signals of HB-EGF mRNA are expressed in relationship to values in gastrin-treated cells (lower panel). Error bars indicate means ± SE (n = 4). Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 3 Expression of (A) TGF-α and (B) BTC mRNAs in RGaR9 cells. Quiescent RGaR9 cells were incubated in serum-free medium with 10−8 mol/L gastrin 17 for the times indicated. (A) Poly(A)+ mRNA or (B) total RNA isolated from the cells was loaded and hybridized with a TGF-α or BTC cDNA probe, respectively. Blots were rehybridized with a GAPDH cDNA probe. Autoradiographs are representative of 4 experiments. (C) Quantitation of TGF-α (•) and BTC (○) mRNAs in A and B. Error bars indicate means ± SE (n = 4). Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 4 Effects of cycloheximide and actinomycin D on gastrin-induced expression of HB-EGF mRNA. Quiescent RGaR9 cells were incubated in serum-free medium with 10−8 mol/L gastrin 17 for 2 hours under the following conditions: lane 1, untreated; lane 2, gastrin 17; lane 3, gastrin 17 with cycloheximide (5 μg/mL); lane 4, cycloheximide; and lane 5, gastrin 17 with actinomycin D (3 μg/mL). Total RNA isolated from the cells was loaded and hybridized with a cDNA probe for rat HB-EGF. Blots were rehybridized with a GAPDH cDNA probe. Autoradiographs are representative of 4 experiments. Normalized hybridization signals are expressed in relationship to values in gastrin-treated cells (lower panel). Error bars indicate means ± SE (n = 4). Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 5 Involvement of (A) PKC and (B) MEK in gastrin-induced expression of HB-EGF and AR mRNAs. Quiescent RGaR9 cells were incubated in serum-free medium with or without 10−8 mol/L gastrin 17 for 2 hours. (A) To inhibit PKC activity, the cells were pretreated with 50–100 nmol/L staurosporine for 15 minutes (lanes 3 and 4) or with 250–500 nmol/L 12-o-tetradecanoyl phorbol 13-acetate (TPA) for 24 hours (lanes 5 and 6) before gastrin stimulation. (B) To inhibit MEK activity, the cells were treated with 50 nmol/L PD 98059 for 15 minutes before gastrin stimulation. Total RNA isolated from the cells was loaded and hybridized with cDNA probes for rat HB-EGF and AR. Blots were rehybridized with a GAPDH cDNA probe. Autoradiographs are representative of 4 experiments. Normalized hybridization signals of HB-EGF mRNA are expressed in relationship to values in gastrin-treated cells (lower panels). Error bars indicate means ± SE (n = 4). Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 6 (A) Effect of gastrin on HB-EGF mRNA expression in isolated parietal cells. Isolated guinea pig parietal cells were prepared as described in Materials and Methods. Cells were incubated in RPMI medium with or without 10−8 mol/L gastrin 17 for 2 hours. Total RNA isolated from the cells was loaded and hybridized with a cDNA probe for rat HB-EGF. Blots were rehybridized with cDNA probes for GAPDH and H+,K+-ATPase. Autoradiographs are representative of 4 experiments. (B) Quantitated hybridization signals are expressed in relationship to the control values. Error bars indicate means ± SE (n = 4). Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 7 (A) Kinetics of cell surface proHB-EGF processing by gastrin. RGaR9 cells were incubated with 10−8 mol/L gastrin 17 for the indicated periods, and cell surface proHB-EGF levels were measured by flow cytometry. Each histogram in A represents 2 × 104 cells. The closed area indicates cells treated with 10−8 mol/L gastrin 17; open areas indicate untreated control cells. (B) The absolute fluorescence intensities of the various time points shown in A were converted to relative fluorescence intensity as described in Materials and Methods. ■, Cells treated with 10−8 mol/L gastrin 17; 2, cells treated with gastrin and 100 nmol/L staurosporine. Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 8 Gastrin-induced cellular secretion of HB-EGF. Confluent RGaR9 cells were incubated in serum-free medium with or without 10−8 mol/L gastrin 17 for the indicated periods. The conditioned media were pooled and applied to a 30-μL heparin–Sepharose CL-6B column. The proteins bound to heparin-Sepharose beads were fractionated by 15% SDS-PAGE and transferred to membranes. HB-EGF protein was detected by Western blot with anti–HB-EGF serum (antiserum 2998), and the results were visualized with an enhanced chemiluminescence detection system (Amersham). Western blots are representative of 4 experiments. Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 9 Gastrin-induced tyrosine phosphorylation of the EGF receptor. (A) RGaR9 cells were stimulated with 10−8 mol/L gastrin 17 (lanes 2–4), 10 ng/mL TGF-α (lane 5), or 10 ng/mL TGF-α with 250 nmol/L AG1478 (lane 6) for the times indicated. (B) The cells were stimulated with 10−8 mol/L gastrin 17 (lane 2), 10−8 mol/L gastrin 17 with antiserum to HB-EGF (antiserum 19, 1/100; lane 3), 10−8 mol/L gastrin 17 with 250 nmol/L AG1478 (lane 4), or 10 ng/mL TGF-α (lane 5) for 15 minutes. The treated cells were lysed, and immunoprecipitation was performed with anti-EGF receptor antibody (αEGFR). The precipitates were separated on SDS-PAGE and transferred to membranes. Immunoblots were probed with antiphosphotyrosine antibody (αPY), and the results were visualized with an Amersham enhanced chemiluminescence detection system. Filters were subsequently stripped of antibody and reprobed with αEGFR. Western blots are representative of 4 experiments. Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 10 Growth-stimulatory effects of (A and B) gastrin 17/CCK-8 and (C) EGF-related polypeptides on RGaR9 cells. Confluent RGaR9 cells in 96-well plates were placed in serum-free medium for 48 hours. The cells were subsequently incubated for 18 hours in serum-free medium with the indicated concentration of gastrin 17, CCK-8, TGF-α, HB-EGF, or AR; they were then labeled with 1 μCi/mL [3H]thymidine 18–22 hours later. The [3H]thymidine incorporated was measured by a Betaplate System (Amersham). Data represent the mean ± SE from 4–6 identical experiments and are expressed as a percentage of the values seen in nonstimulated control cells. *P < 0.05 compared with values in control cells. Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 11 Effects of (A) goat anti-rat HB-EGF serum and (B) tyrphostin AG1478 on gastrin-induced [3H]thymidine incorporation in RGaR9 cells. Quiescent RGaR9 cells were incubated in serum-free medium with 10−8 mol/L gastrin 17 for 18 hours in the presence or absence of goat anti-rat HB-EGF serum (antiserum 19) or 250 nmol/L AG1478. Thereafter, the cells were pulse labeled with [3H]thymidine for 4 hours, and the [3H]thymidine incorporated was measured by a Betaplate System (Amersham). Data represent the mean ± SE from 6 identical experiments and are expressed as a percentage of the values seen in nonstimulated control cells. *P < 0.05 compared with gastrin-treated controls. Gastroenterology 1999 116, 78-89DOI: (10.1016/S0016-5085(99)70231-3) Copyright © 1999 American Gastroenterological Association Terms and Conditions